Brief: Shield Therapeutics Appoints Anders Lundstrom As CEO
27/01/2025 07:19
Jan 27 (Reuters) - Shield Therapeutics PLC STXS.L :
* SHIELD THERAPEUTICS - ANDERS LUNDSTROM APPOINTED CEO
* SHIELD THERAPEUTICS PLC - ANDERS LUNDSTROM APPOINTED CEO
OF
SHIELD THERAPEUTICS
Source text: ID:nRSa6855Ua
Further company coverage: STXS.L
((Reuters.Briefs@thomsonreuters.com))
Recent news on Shield Therapeutics
See all newsBrief: Shield Therapeutics To Assume Full Commercial Control Of ACCRUFeR In US
Shield Therapeutics - Shield assumes full control of ACCRUFeR® in the US
Shield Therapeutics - Interim results for the six months ended 30 Jun 26
Brief: Shield Therapeutics Says On Track For Profitability In 2026; Appoints Michael Jensen As CFO
Shield Therapeutics - Q2 and H1 2026 Trading Update